4Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections[ J ]. Drugs, 1990,39 (4) : 597 - 638.
5Nevins TE, Dunn DL. Use of ganciclovir for cytomegalovirus infection[J ]. J Am Soc Nephrol, 1992,2( 12 suppl) : s270 - s273.
6Elion GB, Furman PA, Fyfe JA, et al. The selectivity of action of an antiherpetic agent, 9- ( 2-hydroxyethoxymethyl ) guanine [ J ]. Rev Med Virol, 1999,9(3) : 147 - 152.
7Steer CB, Szer J, Sasadeusz J, et al. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir[J ]. Bone Marrow Transplant, 2000,25 (6) : 657 - 664.
8McGavin JK,Goa KL. Ganciclovir:an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients[J]. Drugs, 2001,61(8) : 1153-1183.
9Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections [ J ]. Drugs, 1990,39 (4) :597 ～ 638.
10Elion GB,Furman PA,Fyfe JA,et al.The selectivity of action of an antiherpetic agent,9-(2-hydroxyethoxy methyl) guanine.Rev Med Virol,1999,9(3):147-152.
